D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results - Concepedia

Concepedia

Publication | Open Access

D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

DOI Full Paper Access

75

Citations

24

References

2023

Year

Ziming Li, Zhengbo Song, Yanqiu Zhao, Pingli Wang, Liyan Jiang, Yi Gong, Jianying Zhou, Hong Jian, Xiaorong Dong, Zhuang Wu,

Journal of Thoracic Oncology

Novel TherapyPharmacologySelective InhibitorPharmacotherapyMedicinePhase 1Inhibitory ActivityDrug DiscoveryStudy Results

References

	Year	Citations

Page 1

Page 1